Fecal Microbiota Transplantation Among Dogs with Several Different Diseases: Retrospective Cohort Study Between Years 2011–2024
Keywords:
dog, fecal microbiota transplantation, natural, treatmentAbstract
Purpose of the retrospective, present study was to determine whether fecal microbiota transplantation (fMt) from well known, otherwise healthy lean donor dogs could be capable of substituting disease condition from disease to health status, reverting to factory settings and further might improve the life quality of dogs with several different diseases. Taking into account study design, setting and enrollment (along with accompanying archive data) this clinical trial was conducted between 2011 to 2024 among 1,885 diseased dogs with several different system involvement were treated with fMt at median number of 2 to 6 occasions. To those of solely eligible dogs (with witten owner consent, triage position, without systemic inflammatory respond syndrome or other hazardous condition) were recruited for the study. Data were analyzed from March 2011 to June 2024. All fMt interventions from each lean donor (heterologous) were administered either by gastroduodenoscopy (n = 112 into the duodenum) or by rectal enema (n = 1,773 into the colon). Available cure rates ranged from 41.42% to 93.61% regarding entire enrolled dogs. Forest plot denoted an overall response rate of 76%. Highest cure rates (nearly 94%) were deemed available for gastroentero-dermatological disorders to those of satisfactory clinical recovery for each cases enrolled. Lowest cure rates were observed for endocrinological and cardiovascular disease conditions exhibiting 41 and 47%, respectively. Available results were establish future meta-analysis source in which data is lacking. This study should highlighten the efficacy and possible treatment switching modalities to those of uncurable diseases.
References
Arora, U., Kedia, S., & Ahuja, V. (2024). The practice of fecal microbiota transplantation in inflammatory bowel disease. Intestinal Research, 22(1), 44–64. https://doi.org/10.5217/ir.2023.00085
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T. J., et al. (2012). Intestinal inflammation targets cancer-inducing activity of the microbiota. Science, 338, 120–123. https://doi.org/10.1126/science.1224820
Basson, A. R., Trotter, A., Rodriguez-Palacios, A., & Cominelli, F. (2016). Mucosal interactions between genetics, diet, and microbiome in inflammatory bowel disease. Frontiers in Immunology, 7. https://doi.org/10.3389/fimmu.2016.00290
Basson, A. R., Zhou, Y., Seo, B., Rodriguez-Palacios, A., & Cominelli, F. (2020). Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease. Translational Research, 226, 1–11. https://doi.org/10.1016/j.trsl.2020.05.008
Bibbò, S., Settanni, C. R., Porcari, S., Bocchino, E., Ianiro, G., Cammarota, G., et al. (2020). Fecal microbiota transplantation: Screening and selection to choose the optimal donor. Journal of Clinical Medicine, 9(6), 1757. https://doi.org/10.3390/JCM9061757
Borody, T. J., & Khoruts, A. (2011). Fecal microbiota transplantation and emerging applications. Nature Reviews Gastroenterology & Hepatology, 9, 88–96. https://doi.org/10.1038/nrgastro.2011.244
Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., et al. (2019). International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut, 68(12), 2111–2121. https://doi.org/10.1136/gutjnl-2019-319548
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., et al. (2017). European consensus conference on faecal microbiota transplantation in clinical practice. Gut, 66(4), 569–580. https://doi.org/10.1136/gutjnl-2017-313909
Ceccarani, C., Bassanini, G., Montanari, C., Casiraghi, M. C., Ottaviano, E., Morace, G., et al. (2020). Proteobacteria overgrowth and butyrate-producing taxa depletion in the gut microbiota of glycogen storage disease type 1 patients. Metabolites, 10, 133. https://doi.org/10.3390/metabo10040133
Chaitman, J., & Gaschen, F. (2021). Fecal microbiota transplantation in dogs. Veterinary Clinics of North America: Small Animal Practice, 51(1), 219–233. https://doi.org/10.1016/j.cvsm.2020.09.012
Chaitman, J., Jergens, A. E., Gaschen, F., Garcia-Mazcorro, J. F., Marks, S. L., Marroquin-Cardona, A. G., et al. (2016). Commentary on key aspects of fecal microbiota transplantation in small animal practice. Veterinary Medicine (Auckland), 7, 71–74. https://doi.org/10.2147/VMRR.S105238
Chaitman, J., Ziese, A. L., Pilla, R., Minamoto, Y., Blake, A. B., Guard, B. C., et al. (2020). Fecal microbial and metabolic profiles in dogs with acute diarrhea receiving either fecal microbiota transplantation or oral metronidazole. Frontiers in Veterinary Science, 7, 192. https://doi.org/10.3389/fvets.2020.00192
Eiseman, B., Silen, W., Bascom, G. S., & Kauvar, A. J. (1958). Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 44, 854–859.
Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. PNAS, 104, 13780–13785. https://doi.org/10.1073/pnas.0706625104
Haifer, C., Kelly, C. R., Paramsothy, S., Andresen, D., Papanicolas, L. E., McKew, G. L., et al. (2020). Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut, 69(5), 801–810. https://doi.org/10.1136/gutjnl-2019-320260
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., et al. (2012). Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communications, 3, 1245. https://doi.org/10.1038/ncomms2266
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013). Fecal microbiota transplantation for Clostridium difficile infection: Systematic review and meta-analysis. American Journal of Gastroenterology, 108, 500–508. https://doi.org/10.1038/ajg.2013.59
Kelly, B. J., & Tebas, P. (2018). Clinical practice and infrastructure review of faecal microbiota transplantation for Clostridium difficile infection. Chest, 153, 266–277. https://doi.org/10.1016/j.chest.2017.09.002
Li, Y. T., Cai, H. F., Wang, Z. H., Xu, J., & Fang, J. Y. (2016). Systematic review with meta-analysis: Long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Alimentary Pharmacology & Therapeutics, 43, 445–457. https://doi.org/10.1111/apt.13492
Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., et al. (2023). The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut, 72(9), 1642–1650. https://doi.org/10.1136/gutjnl-2023-329948
Marcella, C., Cui, B., Kelly, C. R., Ianiro, G., Cammarota, G., & Zhang, F. (2021). Systematic review: The global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Alimentary Pharmacology & Therapeutics, 53(1), 33–42. https://doi.org/10.1111/apt.16148
Mayer, E. A., Nance, K., & Chen, S. (2022). The gut-brain axis. Annual Review of Medicine, 73, 439–453. https://doi.org/10.1146/annurev-med-042320-014032
Mocanu, V., Rajaruban, S., Dang, J., Kung, J. Y., Deehan, E. C., & Madsen, K. L. (2021). Repeated fecal microbial transplantations and antibiotic pre-treatment are linked to improved clinical response and remission in inflammatory bowel disease: A systematic review and pooled proportion meta-analysis. Journal of Clinical Medicine, 10, 959. https://doi.org/10.3390/jcm10050959
Mukherjee, S., Joardar, N., Sengupta, S., & Sinha Babu, S. P. (2018). Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. Journal of Nutritional Biochemistry, 61, 111–128.
Niina, A., Kibe, R., Suzuki, R., Yuchi, Y., Teshima, T., Matsumoto, H., et al. (2021). Fecal microbiota transplantation as a new treatment for canine inflammatory bowel disease. Bioscience of Microbiota, Food and Health, 40(2), 98–104. https://doi.org/10.12938/bmfh.2020-049
Paramsothy, S., Nielsen, S., Kamm, M. A., Deshpande, N. P., Faith, J. J., Clemente, J. C., et al. (2019). Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology, 156(5), 1440–1454. https://doi.org/10.1053/j.gastro.2018.12.001
Pereira, G. Q., Gomes, L. A., Santos, I. S., Alfieri, A. F., Weese, J. S., & Costa, M. C. (2018). Fecal microbiota transplantation in puppies with canine parvovirus infection. Journal of Veterinary Internal Medicine, 32, 707–711. https://doi.org/10.1111/jvim.15072
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 490, 55–60. https://doi.org/10.1038/nature11450
Quraishi, M. N., Widlak, M., & Bhala, N. (2017). Systematic review with meta-analysis: The efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Alimentary Pharmacology & Therapeutics, 46, 479–493. https://doi.org/10.1111/apt.14201
Rojas, C. A., Entrolezo, Z., Jarett, J. K., Jospin, G., Martin, A., & Ganz, H. H. (2024). Microbiome responses to oral fecal microbiota transplantation in a cohort of domestic dogs. Veterinary Sciences, 11, 42. https://doi.org/10.3390/vetsci11010042
Schmidt, T. S. B., Li, S. S., Maistrenko, O. M., Akanni, W., Coelho, L. P., Dolai, S., et al. (2022). Drivers and determinants of strain dynamics following fecal microbiota transplantation. Nature Medicine, 28, 1902–1913. https://doi.org/10.1038/s41591-022-01913-0
Shen, Z. H., Zhu, C. X., Quan, Y. S., Yang, Z. Y., Wu, S., Luo, W. W., et al. (2018). Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World Journal of Gastroenterology, 24(1), 5. https://doi.org/10.3748/wjg.v24.i1.5
Skjevling, L. K., Hanssen, H. M., Valle, P. C., Goll, R., Juul, F. E., Arlov, Ø., et al. (2023). Colonic distribution of FMT by different enema procedures compared to colonoscopy – proof of concept study using contrast fluid. BMC Gastroenterology, 23, 363. https://doi.org/10.1186/s12876-023-02979-x
Smits, L., Bouter, K., De Vos, W., Borody, T., & Nieuwdorp, M. (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterology, 145, 946–953. https://doi.org/10.1053/j.gastro.2013.08.058
Sugita, K., Shima, A., Takahashi, K., Ishihara, G., Kawano, K., & Ohmori, K. (2023). Pilot evaluation of a single oral fecal microbiota transplantation for canine atopic dermatitis. Scientific Reports, 13, 8824. https://doi.org/10.1038/s41598-023-35565-y
Tian, H., Zhang, S., Qin, H., Li, N., & Chen, Q. (2022). Long-term safety of faecal microbiota transplantation for gastrointestinal diseases in China. The Lancet Gastroenterology & Hepatology, 7, 702–703. https://doi.org/10.1016/S2468-1253(22)00170-4
Toresson, L., Spillmann, T., Pilla, R., Ludvigsson, U., Hellgren, J., Olmedal, G., et al. (2023). Clinical effects of faecal microbiota transplantation as adjunctive therapy in dogs with chronic enteropathies – A retrospective case series of 41 dogs. Veterinary Sciences, 10, 271. https://doi.org/10.3390/vetsci10040271
Ural, K., Erdoğan, H., Adak, H. İ., Ateş, D. S., & Kahraman, D. (2019). Ataksik kedilerde fekal mikrobiyota transplantasyonu. MAE Veteriner Fakültesi Dergisi, 4(1), 34–36. https://doi.org/10.24880/maeuvfd.460765
Ural, K. (2022). Fecal microbiota transplantation capsule therapy via oral route for combatting atopic dermatitis in dogs. Ankara Üniversitesi Veteriner Fakültesi Dergisi, 69, 211–219. https://doi.org/10.33988/auvfd.822971
Wang, J., He, L., Wang, S., Zhao, H., Chen, J., Dong, Y., et al. (2023). Therapeutic effect of the total saponin from Panax japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice. Journal of Ethnopharmacology, 315, 116681. https://doi.org/10.1016/j.jep.2023.116681
Watanangura, A., Meller, S., Farhat, N., Suchodolski, J. S., Pilla, R., Khattab, M. R., et al. (2024). Behavioral comorbidities treatment by fecal microbiota transplantation in canine epilepsy: A pilot study of a novel therapeutic approach. Frontiers in Veterinary Science, 11, 1385469. https://doi.org/10.3389/fvets.2024.1385469
Wingfield, W. E., & Sally, B. (2009). Veterinary disaster response (p. 584). John Wiley & Sons.
Yu, L. W., Agirman, G., & Hsiao, E. Y. (2022). The gut microbiome as a regulator of the neuroimmune landscape. Annual Review of Immunology, 40, 143–167. https://doi.org/10.1146/annurev-immunol-101320-014237
Zhang, S., Chen, Q., Kelly, C. R., Kassam, Z., Qin, H., Li, N., et al. (2022). Donor screening for fecal microbiota transplantation in China: Evaluation of 8483 candidates. Gastroenterology, 162, 966–968.e3. https://doi.org/10.1053/j.gastro.2021.11.004
Zhang, F., Luo, W., Shi, Y., Fan, Z., & Ji, G. (2012). Should we standardize the 1,700-year-old fecal microbiota transplantation? American Journal of Gastroenterology, 107, 1755–1756. https://doi.org/10.1038/ajg.2012.251
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Prof. Kerem Ural, Assoc. Prof. Hasan Erdoğan, Assoc. Prof. Songül eRDOĞAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
